In the sensitivity analyses, elevated ApoB/ApoA-I ratio (≥0.94) was associated with a higher AF risk in individuals with incident HF/CHD but untreated with lipid-lowering drugs. The gene discussed is APOB; the disease is atrial fibrillation.